Back to newsroom
News
2026 Quarterly Impact Update Now Available

March 31, 2026

Pancreatic Cancer North America has released its 2026 Winter Impact Report, highlighting the people, partnerships, and breakthroughs driving progress against one of the deadliest cancers in North America.

Pancreatic Cancer North America

Image of RASONQUE (daraxonrasib) bottle and carton packaging.

Pancreatic Cancer North America has released its 2026 Winter Impact Report, highlighting the people, partnerships, and breakthroughs driving progress against one of the deadliest cancers in North America.

Inside the report, you'll meet the people driving progress and discover how your support is helping transform outcomes across North America. Featured stories include:

  • Honouring Legacies, Changing Outcomes - celebrating the lasting impact of fundraising in honour of a loved one.
  • Turning Passion into Progress - highlighting how community champions are transforming personal passion into meaningful action.
  • Expanding the Ask an Expert Service - exploring how we are expanding patient support programs to strengthen the standard of care for people affected by pancreatic cancer.
  • Building a Next-Generation Early Detection Tool for Pancreatic Cancer - showcasing how investment in research is helping accelerate earlier diagnosis and improve survival.

The 2026 Winter Impact Report offers a snapshot of the progress made possible by our community and the work still ahead. Together, we are building a future where survival is no longer the exception.

Read the 2026 Winter Impact Report.

Be part of the force driving answers for this devastating disease.

Make a donation towards pancreatic cancer research and support programs.

donate today

Keep in the loop:

Read more PCNA News:

discover more

August 28, 2026

Research
Six Months is a Start

August 19, 2026

Research
It's Probably Just Menopause...

July 9, 2026

Research
National Coverage Highlights the Urgent Need for Progress in Pancreatic Cancer